Galectin Therapeutics GALT
NASDAQ GALT
$3.88 -0.03 (-0.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Receivables - Other (2010)

Updated

Galectin Therapeutics (GALT) recorded Receivables - Other of $234,000 in Q4 2010.

Analysis

Galectin Therapeutics (GALT) Receivables - Other (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Galectin Therapeutics 259.28 Mn 259.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 234,000.00
API Access

Galectin Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=GALT&period=max&api_key=YOUR_API_KEY